Herb
    Moderate Evidence

    Mucuna Pruriens

    Mucuna pruriens

    TL;DR

    A legume naturally rich in L-DOPA, the direct precursor to dopamine. Legitimate clinical evidence exists for Parkinson's symptom support; evidence for mood, libido, and stress in healthy people is thinner.

    Ideal For

    • Men with stress-related fertility concerns (some clinical support)
    • People seeking dopaminergic support who understand the drug-like nature of L-DOPA

    Avoid If

    • Anyone on MAOIs, antipsychotics, or prescription levodopa without physician oversight
    • Pregnancy and breastfeeding
    • People with melanoma history, glaucoma, or cardiac arrhythmias

    Frequently Asked Questions

    Overview

    Mucuna pruriens (velvet bean) is unique among supplements because its seeds contain substantial L-DOPA — typically 4-7% by weight — the same pharmaceutical precursor used in Parkinson's disease treatment. This gives it a real, measurable pharmacology unlike most herbal products. Several clinical trials in Parkinson's patients have shown that mucuna seed powder (30 g providing roughly 1 g L-DOPA) produces comparable or faster-onset motor improvements than standard levodopa/carbidopa, with some evidence of fewer dyskinesias, though these studies are small. In healthy populations, small trials suggest benefits for stress-related infertility in men (improved sperm parameters and reduced cortisol) and possibly mood, but these uses rest on limited data. The L-DOPA content makes drug interactions with Parkinson's medications, MAOIs, and antipsychotics a serious consideration.

    How It Works

    • Seeds contain 4-7% L-DOPA, which crosses the blood-brain barrier and is converted directly to dopamine
    • May increase dopamine availability in the nigrostriatal pathway, improving motor symptoms in Parkinson's
    • Antioxidant compounds in seeds may support mitochondrial function
    • Reported to lower cortisol and improve sperm quality in stressed or infertile men, possibly via dopamine-prolactin modulation

    Supporting Research
    6 studies

    Mucuna pruriens in Parkinson disease: a double-blind, randomized, controlled, crossover study

    Score: 7/10
    2017
    crossover
    n=18

    Cilia R, Laguna J, Cassani E

    Mucuna pruriens produced motor benefit comparable to levodopa/benserazide with fewer dyskinesias in the short term.

    View source

    Daily intake of Mucuna pruriens in advanced Parkinson's disease: A 16-week, noninferiority, randomized, crossover, pilot study

    Score: 6/10
    2018
    crossover
    n=14

    Cilia R, Laguna J, Cassani E +4 more

    In those who tolerated MP, clinical response to MP was similar to LD/CD on all efficacy outcome measures.

    View source

    Long-term safety and efficacy of Mucuna pruriens in Parkinson disease: a randomised controlled trial

    Score: 6/10
    2018
    rct
    n=14

    Cilia R, Laguna J, Cassani E

    Over 16 weeks Mucuna maintained motor benefit but caused more gastrointestinal adverse events and dropout than levodopa/carbidopa.

    View source

    Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study

    Score: 6/10
    2004
    crossover
    n=8

    Katzenschlager R, Evans A, Manson A

    Mucuna seed powder gave faster onset and longer on-time than standard levodopa/carbidopa.

    View source

    Levodopa content and safety of Mucuna pruriens preparations: an analytical review

    Score: 5/10
    2012
    systematic_review

    Lampariello LR, Cortelazzo A, Guerranti R

    Levodopa content of commercial Mucuna products varies widely, creating dosing unpredictability.

    View source

    Mucuna pruriens improves sperm parameters and hormonal profile in infertile men

    Score: 5/10
    2009
    rct
    n=150

    Shukla KK, Mahdi AA, Ahmad MK

    Three months of Mucuna seed powder improved sperm count and motility and raised testosterone in infertile men.

    View source

    Safety Information

    Potential Side Effects

    {"Nausea, vivid dreams, and insomnia, especially at higher doses","May worsen psychosis or mania in susceptible individuals","Unregulated products vary widely in actual L-DOPA content"}

    Contraindications

    {"MAOI use","Pregnancy and breastfeeding","History of melanoma, glaucoma, or cardiac arrhythmias"}

    Drug Interactions

    • Levodopa/carbidopa and other Parkinson's drugs: additive dopaminergic effects — requires neurologist supervision
    • MAO inhibitors: risk of hypertensive crisis — contraindicated
    • Antipsychotics (dopamine antagonists): directly opposing mechanisms
    • Antihypertensives: additive blood-pressure lowering possible

    Pregnancy & Breastfeeding

    Pregnancy: likely_unsafe

    Breastfeeding: likely_unsafe

    Dosage Guidelines

    Dosage Used in Studies

    Consult healthcare provider

    Forms Compared

    Preferred for predictable dosing; check L-DOPA percentage on label

    Form used in Parkinson's trials; L-DOPA content varies between batches

    Convenient; verify actual L-DOPA content per capsule

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.